Objective: Shared decision‐making (SDM) integrates patient preferences into evidence‐based care. Generative AI tools may offer a novel approach to facilitate SDM in rhinology, but their clinical utility has not been assessed. Methods: In this prospective randomized pilot study conducted at a single tertiary academic rhinology clinic, English‐speaking adult patients with medically refractory chronic rhinosinusitis (CRS) and/or nasal obstruction were randomized to use either ChatGPT‐4 or Google to ask treatment‐related questions. The primary outcome was change in Decisional Conflict Scale (DCS) score. Secondary outcomes were changes in a treatment‐related knowledge questionnaire (MCQ), system usability scale (SUS) scores, and accuracy ratings of ChatGPT responses. Results: A total of 57 participants completed the study (ChatGPT arm = 29; Google arm = 28). Both groups showed significant reductions in DCS scores with a mean difference of −4.3 in the ChatGPT arm (95% CI: −7.1 to −1.5, p = 0.004) and −2.7 in the Google arm (95% CI: −4.3 to −1.1, p = 0.002), with no significant difference between groups. Participants uncertain about treatment at baseline had higher decisional conflict both pre‐and post‐intervention, and demonstrated less improvement than those who preferred surgery. Treatment preferences and MCQ performance remained unchanged post‐intervention in both groups. SUS scores were comparable between platforms, and ChatGPT's responses were rated as moderately accurate (7.2/10, SD = 2.0). Conclusion: SDM using ChatGPT and Google may reduce decisional conflict in patients considering sinus surgery, though patients with baseline uncertainty may require additional support. Larger, multi‐center trials are needed to validate these tools and explore their integration across diverse settings. Level of Evidence: Level II.
4 August 2026 in Laryngoscope Investigative Otolaryngology
Objective: High volume steroid nasal rinses are often prescribed for chronic rhinosinusitis and allergic rhinitis. Although the general importance of medication adherence is well established, the specific relationship between objectively measured adherence to topical steroid irrigation and patient‐reported clinical outcomes has not been previously demonstrated. This study aims to investigate the effect of topical steroid nasal rinse adherence on patient outcomes. Methods: This prospective longitudinal study recruited 97 patients with chronic rhinosinusitis or allergic rhinitis. All patients were prescribed twice‐daily high‐volume budesonide isotonic saline sinus rinses. Objective adherence data through quantified medication usage were collected over 8 weeks. Patient outcomes were assessed via the 22‐item Sino‐Nasal Outcome Test (SNOT‐22), a sinus discomfort visual analog scale (VAS, 0–100), and patient‐perceived surgery need. Generalized estimating equations were used to analyze the impact of adherence on symptom outcomes. Results: Higher adherence was significantly associated with improvement in both VAS ( β = −0.18, p < 0.001) and SNOT‐22 ( β = −0.10, p = 0.024) but was not associated with increased surgery desire. Median adherence was overall 47.5%, higher in patients with recent sinus surgery (< 3 months: 55.6%) and higher baseline symptom severity (SNOT‐22 ≥ 20: 51.6%), with correspondingly larger improvements in clinical outcomes. Conclusion: Objective adherence to budesonide sinus irrigation significantly associates with improved patient‐reported outcomes, with the strongest benefit seen in patients with higher baseline symptoms and in the early postoperative period. Targeting adherence interventions may yield clinically meaningful improvements in sinonasal quality of life. Level of Evidence: 2.
31 August 2026 in International Forum of Allergy & Rhinology